David Friedecký
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Metabolomics and Mass Spectrometry Studies 19
- Biochemical and Molecular Research 19
- Physiology 20
- Alzheimer's disease research and treatments 8
- Co-authors
- Tomáš Adam (54 shared papers)Edgar Faber (12 shared papers)Lukáš Najdekr (13 shared papers)Petr Barták (5 shared papers)Radana Brumarová (19 shared papers)Hana Janečková (11 shared papers)Miroslav Strnad (6 shared papers)Karel Koberna (5 shared papers)
In The Last Decade
David Friedecký
106 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 121
- Clinical Biochemistry 149
- Hematology 121
- Biochemistry 81
- Molecular Biology 585
- Rheumatology 112
Countries citing papers authored by David Friedecký
This map shows the geographic impact of David Friedecký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Friedecký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Friedecký more than expected).
Fields of papers citing papers by David Friedecký
This network shows the impact of papers produced by David Friedecký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Friedecký. The network helps show where David Friedecký may publish in the future.
Co-authors
The 25 scholars most cited alongside David Friedecký, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 101 | |
| 2 | 2022 | 60 | |
| 3 | 2011 | 41 | |
| 4 | 1999 | 39 | |
| 5 | 2010 | 38 | |
| 6 | 2015 | 35 | |
| 7 | 2005 | 35 | |
| 8 | 2016 | 34 | |
| 9 | 2019 | 31 | |
| 10 | 2015 | 31 | |
| 11 | 2002 | 31 | |
| 12 | 2023 | 26 | |
| 13 | 2017 | 26 | |
| 14 | 2022 | 23 | |
| 15 | 2007 | 23 | |
| 16 | 2012 | 23 | |
| 17 | 2017 | 22 | |
| 18 | 2014 | 22 | |
| 19 | 2016 | 22 | |
| 20 | 2016 | 22 |
About David Friedecký
David Friedecký is a scholar working on Molecular Biology, Physiology, Clinical Biochemistry, Rheumatology and Hematology, having authored 115 papers that have together received 1.3k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (19 papers), Biochemical and Molecular Research (19 papers), Metabolism and Genetic Disorders (18 papers), Chronic Myeloid Leukemia Treatments (14 papers), Microfluidic and Capillary Electrophoresis Applications (10 papers), Chronic Lymphocytic Leukemia Research (10 papers), Eosinophilic Disorders and Syndromes (8 papers) and Alzheimer's disease research and treatments (8 papers). The work is most often cited by research in Clinical Biochemistry (149 citations), Hematology (121 citations), Biochemistry (81 citations), Molecular Biology (585 citations) and Rheumatology (112 citations). David Friedecký has collaborated with scholars based in Czechia, Slovakia and Germany. Frequent co-authors include Tomáš Adam, Edgar Faber, Lukáš Najdekr, Petr Barták, Radana Brumarová, Hana Janečková, Miroslav Strnad, Karel Koberna, Anna Ligasová and Jitka Široká. Their work appears in journals such as Journal of Chromatography A, Clinical Chemistry and Laboratory Medicine (CCLM), International Journal of Molecular Sciences, Journal of Chromatography B and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.